Trials / Recruiting
RecruitingNCT05873634
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
HeartShare Deep Phenotyping Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Accepted
Summary
HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands of the body, resulting in shortness of breath, fluid retention, and fatigue. HeartShare aims to better classify heart failure into subtypes to help develop more personalized treatments for patients, with the hope that this will improve the lives of heart failure patients. To do this, HeartShare is bringing together a large amount of data (including images, such as heart ultrasounds and MRIs and molecular data from the blood, such as genetics) from previously conducted studies and electronic health records, and is gathering new data through participants enrolled in the HeartShare Deep Phenotyping Study.
Conditions
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2023-05-24
- Last updated
- 2026-04-13
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05873634. Inclusion in this directory is not an endorsement.